Search Results - "Talhi, S"

Outcomes of modified-eam conditioned autologous non-cryopreserved hematopoietic sct for lymphoma. A retrospective single-centre study by Bekadja, M. A., Talhi, S., Amani, K., Osmani, S., Brahimi, M., Mazari, M. A., Krim, A., Yafour, N., Entasoltan, B., Bouchama, S., Charef, L., Serradj, F., Bouhass, R., Arabi, A.

Get full text

The use of granulocyte colony stimulating factoR (G-CSF) (filgrastim) alone in the mobilization of stem cell in the autologous stem cell transplantation by Talhi, S, Osmani, S, Brahimi, M, Yafour, N, Bouhass, R, Arabi, A, Bekadja, M.A

Get full text

Plerixafor in the treatment of progenitor cell mobilization failure: First experience in Algeria by Bekadja, M.A, Bouhass, R, Osmani, S, Brahimi, M, Talhi, S, Yafour, N, Arabi, A

Get full text

Epidemiological Data from the Algerian Multiple Myeloma Registry (AMMR) over 2 Years (June 2014-June 2016): Report of the Algerian Multiple Myeloma Study Group (GETMA) by Saidi, M, Abad, MT, Taoussi, S, Ghezlane, C, Hamladji, RM, Ahmed Nacer, R, Belhadri, F, Moussaoui, H, Ait Ali, H, Aftisse, H, Ardjoun, Fz, Belakehal, SE, Rahali, C, Belhani, M, Boudjerra, N, Berkouk, Y, Ramaoun, M, Ahmidatou, H, Bekadja, MA, Talhi, S, Ouldjeriouat, H, Grifi, F, Boughrira, S, Smaili, K, Mesli, N, Bendahmane, F, Hamdi, S, Belkhodja, Fz, Amoura, A, Menia, H, Rechache, H, Zouaoui, Z, El mestari, A, Touhami, H, Mrabet, R, Lakhdari, N, Brahimi, Z, Zeghouati, S, Sidi Mansour, N, Benhalilou, M, Mehalhal, N, Bendjabellah, B, Chehili, W, Bachiri, A, Abderahmani, S, Ouarhlent, Y, Zidani, H, Nekkal, S, Bouchakor, Y, Hamouda, H, Mehdid, F, Saidi, D, Baichi, F, Benakli, M

“…Introduction: Multiple myeloma (MM) is the second hematological malignancy in Western countries with varying incidence across countries and ethnicities. In…”
Get full text

NON-Cryopreserved Hematopoietic STEM CELL Transplantation in Multiple Myeloma. a Single Center Experience in Oran (ALGERIA) by Bekadja, Amine MA, Talhi, Souad ST, Ouldjeriouat, Hafida OH, Soufi, Osmani OS, Brahimi, Mohamed BM, Bouhass, Rachid Amar RB, Yafour, Nabil, Arabi, Abdessamed AA

“…Introduction: For younger patients under 65 years of age, induction followed by high-dose chemotherapy with autologous stem cell transplantation (ASCT) is the…”
Get full text